Quintiles Launches Go-to-market Service for Biopharma

Allume will help biopharmaceutical companies to bring their products to market more quickly and efficiently.

Quintiles has launched a new service to help biopharmaceutical companies launch new products more efficiently.

Allume helps to simplify the launch planning process, while enabling companies to benefit from Quintiles' expertise in local markets and therapeutic categories.

Dean Summerfield, vice-president of consulting at Quintiles, described the new service as "a well-structured and interactive way of accessing the expertise customers need without surrendering strategic control of their asset".

Mr Summerfield pointed out that biopharmaceutical companies want new ways to "optimise product value, expedite market access, mitigate commercialisation risk, yet retain asset value".